Literature DB >> 16380626

CCM3 mutations are uncommon in cerebral cavernous malformations.

D J Verlaan1, J Roussel, S B Laurent, C E Elger, A M Siegel, G A Rouleau.   

Abstract

Cerebral cavernous malformations (CCMs) are characterized by abnormally enlarged capillary cavities without intervening brain parenchyma. Mutations in the gene PDCD10 have been found in CCM families linked to the CCM3 locus. The authors screened this gene in 15 families that did not have a CCM1 or CCM2 mutation. Only two novel mutations were found, suggesting that mutations in this gene may only account for a small percentage of CCM familial cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380626     DOI: 10.1212/01.wnl.0000188903.75144.49

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Multiple cerebral cavernous malformations and a novel CCM3 germline deletion in a German family.

Authors:  Chi-un Choe; Florence Riant; Christian Gerloff; Elisabeth Tournier-Lasserve; Michael Orth
Journal:  J Neurol       Date:  2010-07-11       Impact factor: 4.849

2.  CCM1 gene deletion identified by MLPA in cerebral cavernous malformation.

Authors:  Sabine Gaetzner; Sonja Stahl; Oguzkan Sürücü; Anne Schaafhausen; Birgit Halliger-Keller; Helmut Bertalanffy; Ulrich Sure; Ute Felbor
Journal:  Neurosurg Rev       Date:  2006-12-23       Impact factor: 3.042

3.  Identification of two novel mutations and of a novel critical region in the KRIT1 gene.

Authors:  Vito Guarnieri; Lucia A Muscarella; Rosina Amoroso; Alessandro Quattrone; Massimo E Abate; Michelina Coco; Domenico Catapano; Vincenzo A D'Angelo; Leopoldo Zelante; Leonardo D'Agruma
Journal:  Neurogenetics       Date:  2006-10-17       Impact factor: 2.660

Review 4.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

5.  CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas.

Authors:  F Riant; F Bergametti; H-D Fournier; F Chapon; S Michalak-Provost; M Cecillon; P Lejeune; H Hosseini; C Choe; M Orth; C Bernreuther; G Boulday; C Denier; P Labauge; E Tournier-Lasserve
Journal:  Mol Syndromol       Date:  2013-04-03

6.  CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.

Authors:  Xiangjian Zheng; Chong Xu; Annarita Di Lorenzo; Benjamin Kleaveland; Zhiying Zou; Christoph Seiler; Mei Chen; Lan Cheng; Jiping Xiao; Jie He; Michael A Pack; William C Sessa; Mark L Kahn
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

Review 7.  Cerebral cavernous malformation: new molecular and clinical insights.

Authors:  N Revencu; M Vikkula
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

8.  Clinical impact of CCM mutation detection in familial cavernous angioma.

Authors:  Oguzkan Sürücü; Ulrich Sure; Sabine Gaetzner; Sonja Stahl; Ludwig Benes; Helmut Bertalanffy; Ute Felbor
Journal:  Childs Nerv Syst       Date:  2006-09-16       Impact factor: 1.475

9.  Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.

Authors:  Judith Gault; Issam A Awad; Peter Recksiek; Robert Shenkar; Robert Breeze; Michael Handler; Bette K Kleinschmidt-DeMasters
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

10.  PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway.

Authors:  Xi Ma; Hongshan Zhao; Jingxuan Shan; Feng Long; Yaoyao Chen; Yingyu Chen; Yingmei Zhang; Xiao Han; Dalong Ma
Journal:  Mol Biol Cell       Date:  2007-03-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.